All authorized agents for local manufacturing of medicine  are hereby informed that NMRA would accept  to manufcure a generic product under multiple brands in the same factory with following recommendations  with effect from 17.05.2022

1.     A maximum of two brands allowed for local manufacturing

2.    More than two brands can be considered case by case for export purpose.

3.    Separate application should be submitted for each product

In case of a product withdrawal or withhold due to quality or safety issue, the decision shall be applied for all the said products.

‍

(Date: 28 March 2022)